PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY APPLICATION • Market segmentation by application • Comparison by application • Medical and pharmaceutical - Market size and forecast 2018-2023 • Forensic and identity testing - Market size and forecast 2018-2023 • Agricultural and food safety - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by application PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Increasing quantitative studies on GM crops • Advent of isothermal DNA amplification • Rising demand for gene amplification kits and assays in consumer genetics PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • Agilent Technologies Inc. • bioMérieux SA • Bio-Rad Laboratories Inc. • F. Hoffmann-La Roche Ltd. • Merck KGaA • PerkinElmer Inc. • QIAGEN Group • Siemens Healthineers AG • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Application - Market share 2018-2023 (%) Exhibit 19: Comparison by application Exhibit 20: Medical and pharmaceutical - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Medical and pharmaceutical - Year-over-year growth 2019-2023 (%) Exhibit 22: Forensic and identity testing - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Forensic and identity testing - Year-over-year growth 2019-2023 (%) Exhibit 24: Agricultural and food safety - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Agricultural and food safety - Year-over-year growth 2019-2023 (%) Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Others - Year-over-year growth 2019-2023 (%) Exhibit 28: Market opportunity by application Exhibit 29: Customer landscape Exhibit 30: Market share by geography 2018-2023 (%) Exhibit 31: Geographic comparison Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 33: North America - Year-over-year growth 2019-2023 (%) Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Europe - Year-over-year growth 2019-2023 (%) Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 37: Asia - Year-over-year growth 2019-2023 (%) Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 39: ROW - Year-over-year growth 2019-2023 (%) Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Impact of drivers and challenges Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Abbott Laboratories - Vendor overview Exhibit 49: Abbott Laboratories - Business segments Exhibit 50: Abbott Laboratories - Organizational developments Exhibit 51: Abbott Laboratories - Geographic focus Exhibit 52: Abbott Laboratories - Segment focus Exhibit 53: Abbott Laboratories - Key offerings Exhibit 54: Agilent Technologies Inc. - Vendor overview Exhibit 55: Agilent Technologies Inc. - Business segments Exhibit 56: Agilent Technologies Inc. - Organizational developments Exhibit 57: Agilent Technologies Inc. - Geographic focus Exhibit 58: Agilent Technologies Inc. - Segment focus Exhibit 59: Agilent Technologies Inc. - Key offerings Exhibit 60: bioMérieux SA - Vendor overview Exhibit 61: bioMérieux SA - Business segments Exhibit 62: bioMérieux SA - Organizational developments Exhibit 63: bioMérieux SA - Geographic focus Exhibit 64: bioMérieux SA - Key offerings Exhibit 65: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 66: Bio-Rad Laboratories Inc. - Business segments Exhibit 67: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 68: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 69: Bio-Rad Laboratories Inc. - Segment focus Exhibit 70: Bio-Rad Laboratories Inc. - Key offerings Exhibit 71: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 72: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 73: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 74: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 76: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 77: Merck KGaA - Vendor overview Exhibit 78: Merck KGaA - Business segments Exhibit 79: Merck KGaA - Organizational developments Exhibit 80: Merck KGaA - Geographic focus Exhibit 81: Merck KGaA - Segment focus Exhibit 82: Merck KGaA - Key offerings Exhibit 83: PerkinElmer Inc. - Vendor overview Exhibit 84: PerkinElmer Inc. - Business segments Exhibit 85: PerkinElmer Inc. - Organizational developments Exhibit 86: PerkinElmer Inc. - Geographic focus Exhibit 87: PerkinElmer Inc. - Segment focus Exhibit 88: PerkinElmer Inc. - Key offerings Exhibit 89: QIAGEN Group - Vendor overview Exhibit 90: QIAGEN Group - Product segments Exhibit 91: QIAGEN Group - Organizational developments Exhibit 92: QIAGEN Group - Geographic focus Exhibit 93: QIAGEN Group - Segment focus Exhibit 94: QIAGEN Group - Key offerings Exhibit 95: Siemens Healthineers AG - Vendor overview Exhibit 96: Siemens Healthineers AG - Business segments Exhibit 97: Siemens Healthineers AG - Organizational developments Exhibit 98: Siemens Healthineers AG - Geographic focus Exhibit 99: Siemens Healthineers AG - Segment focus Exhibit 100: Siemens Healthineers AG - Key offerings Exhibit 101: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 102: Thermo Fisher Scientific Inc. - Business segments Exhibit 103: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 104: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 105: Thermo Fisher Scientific Inc. - Segment focus Exhibit 106: Thermo Fisher Scientific Inc. - Key offerings Exhibit 107: Validation techniques employed for market sizing Exhibit 108: Definition of market positioning of vendors

Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.